Related Experiment Video
Updated: Mar 29, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
The Impact of Diabetes on Brain Health in Childhood
1Department of Paediatrics and Adolescent Medicine, Faculty of Medicine, Pavol Jozef Šafarik University, Tr. SNP 1, 040 01 Kosice, Slovakia.
Insights
Childhood diabetes, both type 1 and type 2, impacts brain development and function. Early intervention and good glycaemic control may protect against neurocognitive risks in young patients.
Area of Science:
- Pediatric Endocrinology
- Neuroscience
- Public Health
Background:
- Childhood diabetes incidence is rising globally.
- The brain is a vulnerable target for diabetes complications.
- Traditional focus on microvascular/macrovascular issues overlooks neurodevelopmental impact.
Purpose of the Study:
- Synthesize current knowledge on diabetes' effects on pediatric brain health.
- Review epidemiology, neuroimaging, cognitive outcomes, mechanisms, and clinical implications.
- Highlight the need for brain health monitoring in pediatric diabetes.
Main Methods:
- Narrative review of existing literature.
- Emphasis on studies concerning children and adolescents with diabetes.
- Inclusion of data on neuroimaging, cognitive function, and risk factors.
Main Results:
- Type 1 diabetes (T1D) linked to subtle brain structure/function alterations and mild cognitive deficits.
- Risk factors include hyperglycemia, variability, ketoacidosis; protective factors include stability, tech, support.
- Early-onset Type 2 diabetes (T2D) also shows adverse brain outcomes, cognitive deficits, and mental health burden.
Conclusions:
- Childhood diabetes (T1D & T2D) significantly affects brain development and function.
- Longitudinal studies needed to confirm causality and test interventions.
- Brain health should be recognized as a key complication in pediatric diabetes care.
Abstract:
Background/Objectives: The global incidence of diabetes in childhood is increasing, raising concern about its long-term effects on the developing brain. Although paediatric diabetes research has traditionally focused on microvascular and macrovascular complications, accumulating evidence indicates that the brain is also a vulnerable target. Methods: This narrative review synthesizes current knowledge on the impact of diabetes on brain health in children and adolescents, with emphasis on epidemiology, neuroimaging and cognitive outcomes, underlying mechanisms, risk and protective factors, and clinical implications. Results: In type 1 diabetes (T1D), studies consistently demonstrate subtle but measurable alterations in brain structure, including reduced growth of total, grey, and white matter volumes, alongside functional and microstructural changes. These neurobiological differences are associated with mild deficits in cognition, particularly in attention, executive function, memory, and processing speed. While clinically significant impairment affects a minority, subclinical alterations are common and may accumulate over time. Key risk factors include chronic hyperglycaemia, glycaemic variability, severe hypoglycaemia, diabetic ketoacidosis, and younger age at onset, whereas good glycaemic stability, diabetes technologies, supportive psychosocial environments, and adequate sleep appear protective. Proposed mechanisms involve oxidative stress, neuroinflammation, disrupted insulin signalling, altered cerebral metabolism, and vulnerability of the immature brain during critical developmental windows. Type 2 diabetes (T2D), increasingly diagnosed in youth, is also associated with adverse brain outcomes. Emerging data link early-onset T2D to alterations in brain structure and connectivity, poorer cognitive performance, and increased mental health burden, mediated by hyperglycaemia, insulin resistance, inflammation, and psychosocial stressors. Conclusions: Overall, childhood diabetes-both T1D and T2D-is associated with meaningful effects on brain development and function. Longitudinal and interventional studies are needed to establish causality and determine whether optimizing glycaemic control and psychosocial support can mitigate neurocognitive risk. Recognizing brain health as a potential complication of paediatric diabetes has important implications for monitoring, prevention, and clinical care.
More Related Videos
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
13:35Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules
Published on: June 26, 2017
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....